NEW DELHI, India, August 30, 2012 /PRNewswire/ --
The Indian nutraceutical market is expected to be driven by growth in segments such as Ayurceuticals. This industry is expected to grow from INR 44 bn in FY11 to INR 56 bn in FY15, driven by dietary supplements, primarily vitamin and mineral supplements. Major segments could include body building, weight control, diabetes control, sports nutrition, meal replacement, among others. Naturally derived substances, amino acids, soy-based and protein and peptide supplements could also drive growth.
At the recently concluded Functional Food and Beverages India 2011 conference, Rashmi Upadhya from PwC shared her insights into the key opportunities and challenges around nutraceuticals. Indian consumers place a high amount of trust in traditional products which could drive the growth of Ayurceuticals - ayurvedic ingredients delivered in packaged nutraceutical forms. There is also an increasing usage of encapsulation and nanoceuticals similar to prevailing global trends. However, nutraceuticals sold as OTC products require heavy investments in product promotion and point of purchase visibility. Educating stakeholders across the value chain from physicians to retailers is challenging and pricing still remains a barrier in this price sensitive industry.
To delve into the dynamic trends in nutraceuticals and the latest evolving domestic and global regulations, Fi Conferences is organising Nutraceuticals India 2012 from 9-12 October in Delhi. The main objective of this conference is to navigate the stringent nutraceutical regulatory guidelines and implementing the latest advances in R&D techniques to drive nutraceutical product development in the country. The pre-conference regulatory seminar on 9 October focuses on domestic and global nutraceutical regulations and will be inaugurated by Dr. SS Ghonkrokta, Director Enforcement, FSSAI. The 2-day strategic conference on 10-11 October will be led by thought leaders from British Biologicals, Hexagon Nutrition, Interlink Marketing Consultancy, Plethico Pharmaceuticals, Elder Pharmaceuticals, CFTRI, Zydus Wellness, Cadila Health Care, Alkem Laboratories, Birla Research and Lifesciences and many more. There will also be an exclusive video presentation from the man who coined the term nutraceuticals, Stephen L DeFelice, MD, Founder and Chairman, The Foundation for Innovation in Medicine (FIM). The event will conclude with a unique Nutricosmetic workshop on 12 October led by Dr. Helmut Weidlich, Managing Director, Institute Kurz, Germany. This unique 4-day strategic conference will bring together 150+ Vice Presidents, Directors, Heads of Regulatory, R&D, Production Innovation and Production Development department professionals from food, beverage and pharmaceutical industry all under one roof. For more information, visit http://www.nutraceuticals-india.com/pr.
About UBM India:
UBM India is a subsidiary of UBM plc, which is the second largest independent exhibition organiser in the world. It is the largest trade exhibition organiser in India, responsible for 26 exhibitions in different locations across the country. The company is also involved in the organisation of conference programmes throughout India and in the publications of trade journals and magazines. For further details please visit the UBM India website, http://www.ubmindia.in.
SOURCE Fi Conferences